The global plastic surgery products market is expected to grow at a CAGR of 9.47% during the period 2016-2020.
The growing adoption of laser in aesthetics is another major factor leading to the growth of the market. Lasers are used to treat a broad range of conditions including skin photodamage, dyschromia, wrinkles, unwanted hair and tattoo removal, body contouring, acne, warts, and facial vein removal. Most of these treatments are cost-effective compared to conventional surgical procedures. Thus, the increasing popularity of laser-based treatments will increase the adoption of laser procedures in the market, thereby leading to the overall market growth.
According to the report, one of the major drivers for market growth is the rising importance of plastic surgery products. Plastic surgery has grown significantly over the years with people increasingly focusing on improving their physical appearance. The presence of minimally invasive cosmetic procedures has also increased the use of facial rejuvenation products, breast implant procedures, and facial implantation.
Further, the report states that the treatment costs are high due to monopolistic approach and hidden procedural expenditure associated with implantable medical devices. Moreover, implants and procedures carried out for cosmetic reasons are not reimbursed. Thus, high cost of products is likely to hinder market growth of plastic surgery products globally.
Key questions answered in this report:
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by type
PART 07: Global plastic surgery injectables market